> Elan has blueprinted a plan to expand its operations in South San Francisco and hire 500 new workers. Report
> Avant Immunotherapeutics as forged a collaboration with Select Vaccines to develop new viral vaccines. Report
> NitroMed has inked a licensing deal with Elan to produce an extended-release version of Bidil. Report
> Xencor will collaborate with Boehringer Ingelheim to optimize therapeutic monoclonal antibodies with improved clinical performance. No terms were released. Release
> The FDA has granted Seattle Genetics orphan drug designation to SGN-33 for the treatment of acute myeloid leukemia and to SGN-35 for the treatment of Hodgkin's disease. Release
> Favrille is raising $10 million through a stock offering. Release
> Invitrogen has agreed to manufacture ViaCell's ViaCyte media. Report
And Finally… Binge eating is common, but still hasn't been designated as a psychiatric disorder. Article